Showing results (3031-3040 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|January 19, 2011
Immune recovery after autologous PBSC transplantation without in vitro graft manipulation for refractory systemic lupus erythematosusH Wada, K Terasako, Y Kamiya, et al.
Bone Marrow Transplantation|January 19, 2011
High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphomaN Puig, M Pintilie, T Seshadri, et al.
Bone Marrow Transplantation|January 1, 1990
Haemopoietic stem cell subpopulations in mouse and man: discrimination by differential adherence and marrow repopulating abilityM Y Gordon, A D Bearpark, D Clarke, et al.
Bone Marrow Transplantation|April 20, 2010
Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experienceM C Minnema, S van Dorp, N W C J van de Donk, et al.
Bone Marrow Transplantation|April 20, 2010
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcomeL Öhrmalm, A Lindblom, H Omar, et al.
Bone Marrow Transplantation|April 20, 2010
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasiaJ P Uberti, M-A Agovi, S Tarima, et al.
Bone Marrow Transplantation|April 13, 2010
Auto-SCT induces a phenotypic shift from CMP to GMP progenitors, reduces clonogenic potential and enhances in vitro and in vivo cycling activity defined by (18)F-FLT PET scanningC Woolthuis, A Agool, S Olthof, et al.
Bone Marrow Transplantation|June 16, 2010
Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in a Chinese populationH W Xiao, X Y Lai, Y Luo, et al.
Bone Marrow Transplantation|June 29, 2010
Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCTH Hebart, C Lengerke, P Ljungman, et al.
Bone Marrow Transplantation|June 29, 2010
Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myelomaS M A Kazmi, R M Saliba, M Donato, et al.
Pageof 993